Feb. 21, 2022
By Karen Hunt, Office of Research
An improved method for treating age-related eye diseases is one of nine projects by Washington State University researchers awarded with commercialization gap funding this year.
The Commercialization Gap Fund (CGF) provides funding to help WSU scientists such as Kuen-Ren “Roland” Chen bring their technology from the research laboratory to the market. Chen is developing a microneedle technology that could ultimately help reduce the frequency of intravitreal injections patients need to treat macular degeneration and other age-related eye diseases.